MINI FUTURE LONG - QUEST DIAGNOSTICS | Market Closed - Boerse Frankfurt Warrants 01:20:32 11/05/2024 am IST | ||
| 2.27 EUR | +4.13% |
|
| Current month | -5.17% | ||
| 1 month | +28.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 2.2 | +0.92% | 0 |
| 09/24/09 | 2.18 | +5.83% | 0 |
| 08/24/08 | 2.06 | -2.83% | 0 |
| 07/24/07 | 2.12 | +4.43% | 0 |
| 06/24/06 | 2.03 | -3.79% | 0 |
Real-time Boerse Frankfurt Warrants
Last update May 11, 2024 at 01:20 am IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PZ0YY8 |
| ISIN | DE000PZ0YY85 |
| Date issued | 03/11/2023 |
| Strike | 114.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.17 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.84 € |
|---|---|
| Lowest since issue | 0.95 € |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.4
USD
Average target price
146.7
USD
Spread / Average Target
+6.01%
- Stock Market
- Certificates
- Certificat
